相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory Tract
Francisco M. Marty et al.
CLINICAL INFECTIOUS DISEASES (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
Emmie de Wit et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
Timothy P. Sheahan et al.
NATURE COMMUNICATIONS (2020)
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
Sangeun Jeon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract
Yixuan J. Hou et al.
CELL (2020)
An Infectious cDNA Clone of SARS-CoV-2
Xuping Xie et al.
CELL HOST & MICROBE (2020)
Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential
Jimin Xu et al.
ACS INFECTIOUS DISEASES (2020)
Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State
Eli S. Rosenberg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
Calvin J. Gordon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
Jianjun Gao et al.
BIOSCIENCE TRENDS (2020)
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
Philippe Gautret et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
Ka-Tim Choy et al.
ANTIVIRAL RESEARCH (2020)
Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study
Abdo A. Elfiky
LIFE SCIENCES (2020)
No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
J. M. Molina et al.
MEDECINE ET MALADIES INFECTIEUSES (2020)
Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
Brandi N. Williamson et al.
NATURE (2020)
A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation
Antonio E. Muruato et al.
NATURE COMMUNICATIONS (2020)
Sofosbuvir as a potential alternative to treat the SARS-CoV-2 epidemic
Rodrigo Jacome et al.
SCIENTIFIC REPORTS (2020)
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice
Andrea J. Pruijssers et al.
CELL REPORTS (2020)
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2
Jianhui Nie et al.
EMERGING MICROBES & INFECTIONS (2020)
Discovery of the pan-genotypic hepatitis C virus NS3/4A protease inhibitor voxilaprevir (GS-9857): A component of Vosevi®
James G. Taylor et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Discovery of velpatasvir (GS-5816): A potent pan-genotypic HCV NS5A inhibitor in the single-tablet regimens Vosevi® and Epclusa®
John O. Link et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Targeting BTK in CLL: Beyond Ibrutinib
David A. Bond et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2019)
In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit
Takeshi Noshi et al.
ANTIVIRAL RESEARCH (2018)
Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1-Infected Adults
Joel E. Gallant et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2017)
Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo(2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses
Dustin Siegel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Timothy P. Sheahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process
Michel Perron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Pharmacokinetics and Safety of Tenofovir Alafenamide in HIV-Uninfected Subjects with Severe Renal Impairment
Joseph M. Custodio et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis
Evelien Vanderlinden et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Design and structure-activity relationships of novel inhibitors of human rhinovirus 3C protease
S. P. Kawatkar et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
An Infectious cDNA Clone of Zika Virus to Study Viral Virulence, Mosquito Transmission, and Antiviral Inhibitors
Chao Shan et al.
CELL HOST & MICROBE (2016)
SARS and MERS: recent insights into emerging coronaviruses
Emmie de Wit et al.
NATURE REVIEWS MICROBIOLOGY (2016)
Molecular Basis for the Selective Inhibition of Respiratory Syncytial Virus RNA Polymerase by 2′-Fluoro-4′-Chloromethyl-Cytidine Triphosphate
Jerome Deval et al.
PLOS PATHOGENS (2015)
Preclinical Characterization of the Novel Hepatitis C Virus NS3 Protease Inhibitor GS-9451
Huiling Yang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Discovery of GS-9669, a Thumb Site II Non-Nucleoside Inhibitor of NS5B for the Treatment of Genotype 1 Chronic Hepatitis C Infection
Scott E. Lazerwith et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery of the First C-Nucleoside HCV Polymerase Inhibitor (GS-6620) with Demonstrated Antiviral Response in HCV Infected Patients
Aesop Cho et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection
John O. Link et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Coronavirus reverse genetic systems: Infectious clones and replicons
Fernando Almazan et al.
VIRUS RESEARCH (2014)
Effect of chloroquine on feline infectious peritonitis virus infection in vitro and in vivo
Tomomi Takano et al.
ANTIVIRAL RESEARCH (2013)
Antiviral Activity, Safety, and Pharmacokinetics/Pharmacodynamics of Tenofovir Alafenamide as 10-Day Monotherapy in HIV-1–Positive Adults
Peter J. Ruane et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2013)
Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus
Trevor Scobey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Discovery of GS-9256: A novel phosphinic acid derived inhibitor of the hepatitis C virus NS3/4A protease with potent clinical activity
X. Christopher Sheng et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis
Vlad Ratziu et al.
HEPATOLOGY (2012)
Pharmacokinetics and inhibitory quotient of atazanavir/ritonavir versus lopinavir/ritonavir in HIV-infected, treatment-naive patients who participated in the CASTLE Study
Li Zhu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
A 2′-DEOXY-2′-FLUORO-2′-C-METHYL URIDINE CYCLOPENTYL CARBOCYCLIC ANALOG AND ITS PHOSPHORAMIDATE PRODRUG AS INHIBITORS OF HCV NS5B POLYMERASE
Jian Liu et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2012)
Mechanistic Characterization of GS-9190 (Tegobuvir), a Novel Nonnucleoside Inhibitor of Hepatitis C Virus NS5B Polymerase
I-hung Shih et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Development and characterization of a stable luciferase dengue virus for high-throughput screening
Gang Zou et al.
ANTIVIRAL RESEARCH (2011)
Cobicistat (GS-9350): A Potent and Selective Inhibitor of Human CYP3A as a Novel Pharmacoenhancer
Lianhong Xu et al.
ACS MEDICINAL CHEMISTRY LETTERS (2010)
Robust Antiviral Efficacy upon Administration of a Nucleoside Analog to Hepatitis C Virus-Infected Chimpanzees
Steven S. Carroll et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Intracellular metabolism of the nucleotide prodrug GS-9131, a potent anti-human immunodeficiency virus agent
Adrian S. Ray et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Pharmacokinetics and safety of saquinavir/ritonavir and omeprazole in HIV-infected subjects
K. Singh et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Inhibition of hepatitis B virus polymerase by entecavir
David R. Langley et al.
JOURNAL OF VIROLOGY (2007)
Short-term antiviral activity of TMC278 -: a novel NNRTI -: in treatment-naive HIV-1-infected subjects
Frank Goebel et al.
AIDS (2006)
High-throughput assays using a luciferase-expressing replicon, virus-like particles, and full-length virus for West Nile virus drug discovery
F Puig-Basagoiti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Discovery and selection of TMC114, a next generation HIV-1 protease inhibitor
DLNG Surleraux et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Exogenous ACE2 expression allows refractory cell lines to support severe acute respiratory syndrome coronavirus replication
EC Mossel et al.
JOURNAL OF VIROLOGY (2005)
Once-daily versus twice-daily Lopinavir/Ritonavir in antiretroviral-naive HIV-positive patients: A 48-week randomized clinical trial
JJ Eron et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Efficacy and safety of emtricitabine vs stavudine in combination therapy in anti retroviral-naive patients - A randomized trial
MS Saag et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients
RK Zeldin et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Pharmacokinetic characterization of different dose combinations of coadministered tipranavir and ritonavir in healthy volunteers
TR MacGregor et al.
HIV CLINICAL TRIALS (2004)
Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers
FG Hayden et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections
E De Clercq
CLINICAL MICROBIOLOGY REVIEWS (2003)
Indinavir plasma protein binding in HIV-1-infected adults
PL Anderson et al.
AIDS (2000)
Nelfinavir - An update on its use in HIV infection
A Bardsley-Elliot et al.
DRUGS (2000)
分享论文
